{
     "PMID": "24775184",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20150206",
     "LR": "20140617",
     "IS": "1755-5949 (Electronic) 1755-5930 (Linking)",
     "VI": "20",
     "IP": "7",
     "DP": "2014 Jul",
     "TI": "Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats.",
     "PG": "671-8",
     "LID": "10.1111/cns.12275 [doi]",
     "AB": "AIMS: Serotonin (5-HT) neurons mediate the ectopic release of dopamine (DA) induced by L-DOPA in the Parkinsonian brain. We hypothesized that the participation of noradrenalin transporters (NET) in the clearance of DA may account for the lower effect of L-DOPA in extrastriatal regions compared with the striatum. METHODS: Using a multisite intracerebral microdialysis approach, we tested the influence of the pharmacological blockade of NET and/or the destruction of noradrenalin (NE) fibers on DA and 5-HT release in the striatum, hippocampus (HIPP), substantia nigra pars reticulata (SNr) and prefrontal cortex (PFC) of 6-hydroxydopamine-lesioned rats. RESULTS: L-DOPA (12 mg/kg, i.p.) increased DA extracellular levels to a lesser extent in the SNr, PFC and HIPP compared with the striatum. The NET blockers desipramine (10 mg/kg, i.p.) and reboxetine (3 mg/kg, i.p.) potentiated L-DOPA effect in the PFC, SNr and HIPP but not in the striatum. The NE neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (50 mg/kg, i.p. 1 week before dialysis experiment) potentiated L-DOPA effect in the SNr and HIPP. 5-HT extracellular levels were enhanced only when L-DOPA was combined to NET blockers. CONCLUSION: Noradrenalin neurons are indirectly involved in the mechanism of action of L-DOPA in part through the heterologous reuptake of DA in extrastriatal regions.",
     "CI": [
          "(c) 2014 John Wiley & Sons Ltd."
     ],
     "FAU": [
          "Navailles, Sylvia",
          "Milan, Lea",
          "Khalki, Hanane",
          "Di Giovanni, Giuseppe",
          "Lagiere, Melanie",
          "De Deurwaerdere, Philippe"
     ],
     "AU": [
          "Navailles S",
          "Milan L",
          "Khalki H",
          "Di Giovanni G",
          "Lagiere M",
          "De Deurwaerdere P"
     ],
     "AD": "Universite de Bordeaux, Bordeaux Cedex, France; Unite Mixte de Recherche 5293, Centre National de la Recherche Scientifique, Bordeaux Cedex, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140428",
     "PL": "England",
     "TA": "CNS Neurosci Ther",
     "JT": "CNS neuroscience & therapeutics",
     "JID": "101473265",
     "RN": [
          "46627O600J (Levodopa)",
          "VTD58H1Z2X (Dopamine)"
     ],
     "SB": "IM",
     "MH": [
          "Adrenergic Neurons/drug effects/*physiology",
          "Animals",
          "Cerebral Cortex/drug effects/*metabolism",
          "Corpus Striatum/drug effects/*metabolism",
          "Dopamine/*metabolism",
          "Extracellular Fluid/metabolism",
          "Levodopa/*pharmacology/therapeutic use",
          "Male",
          "Parkinsonian Disorders/drug therapy/*metabolism",
          "Rats",
          "Rats, Sprague-Dawley"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Dopamine",
          "Intracerebral microdialysis",
          "Noradrenergic terminals",
          "Serotonin",
          "l-DOPA"
     ],
     "EDAT": "2014/04/30 06:00",
     "MHDA": "2015/02/07 06:00",
     "CRDT": [
          "2014/04/30 06:00"
     ],
     "PHST": [
          "2014/02/13 00:00 [received]",
          "2014/03/26 00:00 [revised]",
          "2014/03/27 00:00 [accepted]",
          "2014/04/30 06:00 [entrez]",
          "2014/04/30 06:00 [pubmed]",
          "2015/02/07 06:00 [medline]"
     ],
     "AID": [
          "10.1111/cns.12275 [doi]"
     ],
     "PST": "ppublish",
     "SO": "CNS Neurosci Ther. 2014 Jul;20(7):671-8. doi: 10.1111/cns.12275. Epub 2014 Apr 28.",
     "term": "hippocampus"
}